EDGEWOOD MANAGEMENT LLC – Vertex Pharmaceuticals Incorporated Transaction History
EDGEWOOD MANAGEMENT LLC portfolio value:
$5.34M
portfolio value
EDGEWOOD MANAGEMENT LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -23.41% | -5.63K shares | -1.44M | $289.54 | 18.45K |
Q2 2022 | share | 0.00% | 0 shares | 502K | $281.79 | 24.08K | |
Q1 2022 | share | 0.00% | 0 shares | 996K | $260.97 | 24.08K | |
Q4 2021 | share | 0.00% | 0 shares | 921K | $222.45 | 24.08K | |
Q3 2021 | share | Decrease | -38.37% | -15K shares | -3.51M | $181.39 | 24.08K |
Q2 2021 | share | 0.00% | 0 shares | -519K | $201.63 | 39.08K | |
Q1 2021 | share | 0.00% | 0 shares | -838K | $214.89 | 39.08K | |
Q4 2020 | share | 0.00% | 0 shares | -1.39M | $236.34 | 39.08K | |
Q3 2020 | share | 0.00% | 0 shares | -711K | $272.12 | 39.08K | |
Q2 2020 | share | Decrease | -5.93% | -2.46K shares | 1.46M | $290.31 | 39.08K |
Q1 2020 | share | Decrease | -10.93% | -5.1K shares | -327K | $237.95 | 41.55K |
Q4 2019 | share | Increase | +33.29% | 11.65K shares | 4.28M | $218.95 | 46.65K |
Q3 2019 | share | 0.00% | 0 shares | -488K | $169.42 | 35K | |
Q2 2019 | share | 0.00% | 0 shares | -20K | $183.38 | 35K | |
Q1 2019 | share | 0.00% | 0 shares | 638K | $183.95 | 35K | |
Q4 2018 | share | 0.00% | 0 shares | -946K | $165.71 | 35K | |
Q3 2018 | share | 0.00% | 0 shares | 797K | $192.74 | 35K | |
Q2 2018 | share | 0.00% | 0 shares | 245K | $169.96 | 35K | |
Q1 2018 | share | Decrease | -8.61% | -3.29K shares | -35K | $162.98 | 35K |
Q4 2017 | share | 0.00% | 0 shares | -84K | $149.86 | 38.29K | |
Q3 2017 | share | Decrease | -0.14% | -54 shares | 880K | $152.04 | 38.29K |
Q2 2017 | share | 0.00% | 0 shares | 749K | $128.87 | 38.35K | |
Q1 2017 | share | Decrease | -0.20% | -75 shares | 1.36M | $109.35 | 38.35K |
Q4 2016 | share | 0.00% | 0 shares | -520K | $73.67 | 38.42K | |
Q3 2016 | share | 0.00% | 0 shares | 45K | $87.21 | 38.42K | |
Q2 2016 | share | 0.00% | 0 shares | 251K | $86.02 | 38.42K | |
Q1 2016 | share | Decrease | -40.37% | -26.01K shares | -5.05M | $79.49 | 38.42K |